Nintedanib is a kinase inhibitor active pharmaceutical ingredient used in the manufacturing of medications for idiopathic pulmonary fibrosis and certain types of non-small-cell lung cancer.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 928326-83-4
Nintedanib
pharmaceutical raw material
Nintedanib esylate
pharmaceutical raw material
Intedanib Piperazinyl-N4-oxide
pharmaceutical raw material
Intedanib Piperazinyl-N4-oxide
research compound
(Z)-1-(2-((4-(((6-(methoxycarbonyl)-2-oxoindolin-3-ylidene)(phenyl)methyl)amino)phenyl)(methyl)amino)-2-oxoethyl)-4-methylpiperazine 1-oxide
research compound
Ripretinib
pharmaceutical raw material
Canagliflozin hemihydrate
pharmaceutical raw material
Seladelpar lysine dihydrate
pharmaceutical raw material
methyl 2-hydroxy-3-[N-[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]phenyl]-C-phenylcarbonimidoyl]-1H-indole-6-carboxylate
CPMDPSXJELVGJG-UHFFFAOYSA-N
CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N=C(C3=CC=CC=C3)C4=C(NC5=C4C=CC(=C5)C(=O)OC)O